Combination Cancer Therapy Modulators and Potentiators /

Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer T...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Schwartz, Gary K. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2005.
Edición:1st ed. 2005.
Colección:Cancer Drug Discovery and Development,
Temas:
Oncology.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Targeting of the EGFR As a Modulator of Cancer Chemotherapy
  • Cyclin-Dependent Kinase Inhibitors in Combination Chemotherapy
  • Development of Protein Kinase C and Cyclin-Dependent Kinase Inhibitors As Potentiators of Cytotoxic Drug Action in Leukemia
  • Carboxyamidotriazole, an Inhibitor of Nonvoltage-Operated Calcium Entry
  • Targeted ?-Particle Therapy
  • Pharmacological Modulation of Fluoropyrimidines
  • Development of Inhibitors of HER2 With Taxanes
  • Targeting NF-?B to Increase the Activity of Cisplatin in Solid Tumors
  • Combinations of Chemotherapy and G3139, an Antisense Bcl-2 Oligonucleotide
  • Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy.

Ejemplares similares